Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

A Look into the Future of Chronic Pain Management

An Interview with Innocan Pharma’s CEO, Iris Bincovich. Innocan Pharma is gaining attention for its innovative pain relief solutions — particularly through its slow-release injection technology. This cutting-edge approach delivers synthetic Cannabidi...

NervGen Pharma: Proof that NVG-291 works?

It’s arguably a Eureka moment for investors in NervGen Pharma (TSX.V: NGEN) (OTCQB: NGENF). Tantalizing anecdotal “evidence” has just been published that suggests that NervGen’s prospective wonder-drug — NVG-29...

dynaCERT: Growth Rocket 2025 – Why It’s in the Spotlight

As 2024 draws to a close, it is worth considering new investments for the future. A successful investment in the technology sector requires a sound strategy, thorough research, and an understanding of the ins and outs of the industry. We have summarized key points for in...

In conversation with: Pierre Gratton: How can we built more mines faster in Canada?

The Mining Association of Canada’s President and CEO Pierre Gratton discusses his Vancouver Board of Trade presentation addressing the question, “How can we build more mines faster? He covers several key issues including, the need for critical miner...

NurExone Biologic announces important test results

By Brad Sorensen, CFA, Zacks Research. NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting preclinical tests for other conditions that ExoPTEN m...

From now on, dynaCERT instead of Bitcoin or NVIDIA?

While Bitcoin and NVIDIA dominate the headlines and investors hope for the next rally, a promising opportunity is emerging with dynaCERT Inc. (ISIN: CA26780A1084 | Ticker-TSX: DYA) for those seeking a true growth story. Read on to learn why this Canadian company may now b...

Here are three global stocks you should watch

Taking a macro or global view on stocks can be educational and offer a different view on the economy. Alpha Ba , portfolio manager specializing in global and emerging markets equities with Pillow Investments , gives us his three global stock picks. The three stock ...

Unique Battery Metals opportunity in Quebec

Coniagas Battery Metals Inc (TSXV:V.COS ), a Canadian Junior Mining Company focused on nickel, copper, cobalt and platinum group metals in Quebec. The Market Online recently sat down again with CEO and Director, Frank Basa The following is a transcription of the abo...

Visionstate set to leverage success in the U.S. market

The following is a transcription of the above video, and The Market Online has edited it for clarity . Visionstate Corp (TSXV:VIS) , a company whose vision is to be the leading global provider of IoT solutions for facility management. Their flagship software WANDA i...

Debt-free cannabis company set for next stage of growth

The following is a transcription of the above video, and The Market Online has edited it for clarity . Nextleaf Solutions (CSE:OILS) , is a debt-free cannabis processor known for its multi patented, scalable extraction technology. The company offers a diverse portfo...
1 2 3 4 5 6 7 8 9 10 ...